organophosphonates has been researched along with iqp-0528 in 2 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (iqp-0528) | Trials (iqp-0528) | Recent Studies (post-2010) (iqp-0528) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 10 | 0 | 9 |
| Protein | Taxonomy | organophosphonates (IC50) | iqp-0528 (IC50) |
|---|---|---|---|
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 2.3335 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckheit, KW; Buckheit, RW; Goldman, L; Gwozdz, G; Ham, AS; Kiser, PF; Lakougna, H; Nagaraja, U; Shi, L; Ugaonkar, SR | 1 |
| Buckheit, KW; Buckheit, RW; Dezzutti, CS; Gwozdz, G; Mahalingam, A; Shetler, C; Ugaonkar, SR | 1 |
2 other study(ies) available for organophosphonates and iqp-0528
| Article | Year |
|---|---|
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Anti-Infective Agents; Cell Line; Chemistry, Pharmaceutical; Excipients; Gels; HIV-1; Humans; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Solubility; Tenofovir; Viscosity | 2012 |
Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention.
Topics: Adenine; Administration, Mucosal; Anti-Infective Agents; Cell Line; Cell Survival; Chemoprevention; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Organophosphonates; Pyrimidinones; Tenofovir; Tissue Culture Techniques; Vaginal Creams, Foams, and Jellies | 2012 |